Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 3/20 | 0.62 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.61 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.61 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.61 |
| ▸ | NPY2R | P49146 | 8/20 | 0.61 |
| ▸ | NPY4R | P50391 | 8/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.61 |
| ▸ | NPY1R | P25929 | 6/20 | 0.61 |
| ▸ | CALCR | P30988 | 3/20 | 0.57 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.56 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.56 |
| ▸ | EP300 | Q09472 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607311 | 0.91 | KEAP1 (0.60) | KEAP1MAPK8MAPK9MAPK10NPY2R | |
| SCHEMBL30607310 | 0.88 | CALCR (0.66) | KEAP1MAPK8MAPK9MAPK10NPY2R | |
| SCHEMBL30432155 | 0.88 | CALCR (0.64) | KEAP1MAPK8MAPK9MAPK10NPY2R | |
| SCHEMBL30658336 | 0.88 | KEAP1 (0.63) | KEAP1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30495784 | 0.88 | NPY2R (0.70) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30248619 | 0.88 | MAPK8 (0.59) | KEAP1MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL30495645 | 0.87 | CALCR (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29754385 | 0.87 | MAPK8 (0.64) | KEAP1MAPK8MAPK9MAPK10NPY2R | |
| SCHEMBL30437173 | 0.87 | NPY2R (0.63) | KEAP1MAPK8MAPK9MAPK10NPY2R | |
| SCHEMBL30974287 | 0.87 | MAPK8 (0.60) | KEAP1MAPK8MAPK9MAPK10NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |